Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow A
Agilent Technologies, Inc. (A) Current ratio
Agilent Technologies, Inc.'s current ratio at the end of the quarter to 31 July 2026 was 2.1×, up 0.1× from fiscal 2025 (2.0×). Over the past ten years it has ranged from 1.5× (fiscal 2019) to 3.8× (fiscal 2016); the current reading is higher than 18% of that period. That is in line with the Diagnostics & Research industry median of 2.0× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.0× | (6.31%) |
| FY2024 | 2.1× | (20.00%) |
| FY2023 | 2.6× | 28.63% |
| FY2022 | 2.0× | (8.73%) |
| FY2021 | 2.2× | (4.45%) |
| FY2020 | 2.3× | 51.83% |
| FY2019 | 1.5× | (53.34%) |
| FY2018 | 3.3× | (0.45%) |
| FY2017 | 3.3× | (14.19%) |
| FY2016 | 3.8× | 1.85% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jul 2026 | 2.1× | (2.33%) |
| Apr 2026 | 2.1× | 1.62% |
| Jan 2026 | 2.1× | 5.54% |
| Oct 2025 | 2.0× | (12.92%) |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| NTRA Natera, Inc. compare | 3.0× |
| A Agilent Technologies, Inc. | 2.1× |
| WAT Waters Corporation compare | 1.9× |
| ILMN Illumina, Inc. compare | 1.8× |
| LH Labcorp Holdings Inc. compare | 1.8× |
| DGX Quest Diagnostics Incorporated compare | 1.6× |
| IDXX IDEXX Laboratories, Inc. compare | 1.2× |
| MTD Mettler-Toledo International, Inc. compare | 1.1× |
| IQV IQVIA Holdings Inc. compare | 0.7× |
| Diagnostics & Research industry median | 2.0× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement